Targeted Oncology10 天
Newly diagnosed Diagnosed mHSPC: Goals of Therapy
Evan Y. Yu, MD, discusses how the goals of therapy for a patient with newly- diagnosed metastatic hormone-sensitive prostate ...
Targeted Oncology9 天
Fellow's Perspective: Impact of Quadruplet and MRD in Newly Diagnosed Multiple Myeloma
In a discussion with Peers & Perspectives in Oncology, fellowship program director Marc J. Braunstein, MD, PhD, FACP, and ...
The American Journal of Managed Care9 天
Fixed-Duration Epcoritamab Is Active, Safe in Older Patients With Newly Diagnosed LBCL
Epcoritamab-bysp showed a 69% objective response rate and 62% complete response rate in older patients with large B-cell ...